Navigation Links
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
Date:12/14/2007

million new cases of EGW are seen each year in the United States and nearly 1.4 million sexually active adults have visible genital warts at any point in time. Current treatment for this condition primarily consists of cryosurgery and the topical therapy Aldara(R) (imiquimod).

Both the Doak Dermatologics and Kenwood Therapeutics divisions of Bradley will promote Veregen(TM) to specialty markets including dermatology and female healthcare providers.

"EGW is a condition that is both emotionally and physically distressing for patients," stated Gerald Wachs, M.D., Medical Director of Bradley Pharmaceuticals. "We believe that Veregen(TM), an effective and safe alternative in the treatment of this condition, will enhance patient care."

"Investigations of catechins have shown wide-ranging effects on mechanisms where HPV infection progresses to genital warts," stated Warner K. Huh, M.D., Associate Professor, Division of Gynecologic Oncology, University of Alabama at Birmingham. "Veregen(TM) has been shown to be efficacious and generally well tolerated in patients with genital warts. There was also a relatively low rate of recurrence."

"We are pleased to launch Veregen(TM) as a new therapeutic option," stated Daniel Glassman, President and CEO of Bradley Pharmaceuticals, Inc. "The manufacture of this product is very complex, and I would like to commend everyone involved on achieving our goal of bringing Veregen(TM) to market in 2007. We are all very proud of this therapy and the steps we will be taking in advancing the treatment of EGW."

Veregen(TM) will begin shipping to wholesalers and be available in drugstores within a few weeks.

Important Product Safety Information About Veregen(TM):

Veregen(TM) is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.

Veregen(TM) has not been evaluated to treat urethral, intra-vaginal, cer
'/>"/>

SOURCE Bradley Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... a US-based thermoforming company, has completed the delivery of Brookfield ... metal to a plastic enclosure with a smaller footprint and ... ... MA (PRWEB) December 14, 2009 -- ThermoFab, a US-based thermoforming ... Tester – helping Brookfield move from sheet metal to a ...
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), today announced ... from sales of Thalomid® during the third quarter ... In addition, the Company anticipates a decrease ... 2009. The difference in estimated and actual ... in the fourth quarter financial results. ,, (Logo: ...
(Date:12/11/2009)... BOULDER, Colo., December 10, 2009 miRagen Therapeutics, ... lives by developing innovative microRNA-based therapeutics for cardiovascular ... data demonstrating that microRNA-206 (miR-206) plays a crucial ... (ALS or Lou Gehrig,s disease) and in neuromuscular ... in the December 11 issue of the journal ...
(Date:12/11/2009)... (12/11/2009) Boston College researchers have observed the "hot ... time and successfully harvested the elusive charges using ultra-thin ... power efficiency, the authors report in the current online ... light is captured in solar cells, it generates free ... order to snare these charges, the electrons must reach ...
Breaking Biology Technology:Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2
... interesting lesson. , ,In 1970, Dr. Winston Royce ... Large Software Systems. Appearing in Proceedings, IEEE Wescon, the ... would plague the software industry for decades to come. ... make the great mistake. , , Birth of waterfall ...
... - Having survived two rounds of judging, 26 entries from ... fourth annual Wisconsin Governor's Business Plan Contest . , ... nearly 300 entries statewide, and they represent some of the ... Wisconsin Technology Council . , ,The 26 remaining plans include ...
... Wis. - Phillips Plastics Corp. , a ... Prescott, Wis., has entered into a collaborative agreement with ... stem cell therapeutics for orthopedic applications. , ,The agreement ... drug discovery and therapeutic research, represents a convergence of ...
Other Biology Technology:Are you doomed to repeat the great software mistake? 2Are you doomed to repeat the great software mistake? 3Are you doomed to repeat the great software mistake? 4Business plan finalists capture technology 2Phillips Plastics to help develop orthopedics with stem cells 2Phillips Plastics to help develop orthopedics with stem cells 3
(Date:12/11/2009)... has granted an 18-month, exclusive option to startup ... analogs. The company must reach certain milestones in ... exclusive license on therapies designed to help patients ... treatments that it hopes will become an important ... market. Insulin is a therapeutic protein used to ...
(Date:12/11/2009)... Arno Motulsky, the senior editor of the 4th edition ... Human Genetics, was recently given the Victor A. McKusick ... contributions to the field of human genetics, was presented ... American Society of Human Genetics on 24 October 2009 ... Medicine and Genome Sciences at the University of Washington ...
(Date:12/11/2009)... common knowledge that smoking is a health risk but ... than adults? In an evaluation for Faculty of 1000 ... prone to substance abuse. , Grunberg describes the study, ... journal, as "fascinating" and suggests it "may have implications ... drug abuse". , Nicotine increases the level of dopamine ...
Breaking Biology News(10 mins):Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines 55360 1iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines 55360 2iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines 55360 3Headsets Direct Blog Becomes Real Time Help Desk for Plantronics Headset Questions 55357 1Headsets Direct Blog Becomes Real Time Help Desk for Plantronics Headset Questions 55357 2Headsets Direct Blog Becomes Real Time Help Desk for Plantronics Headset Questions 55357 3Frost 26 Sullivan 3A Growing Healthcare Tourism in Malaysia 55354 1Frost 26 Sullivan 3A Growing Healthcare Tourism in Malaysia 55354 2Frost 26 Sullivan 3A Growing Healthcare Tourism in Malaysia 55354 3
... The special issue (Volume 37, Number 6) of ... first report on all documents related to environment and ... UN General Assembly (UN/GA). During the session at UN ... to many of the worlds most pressing problems was ...
... leader in recent research on the interaction of ... illness, Avshalom Caspi, Ph.D. of King,s College London, ... Prize for Distinguished Achievement in Developmental Psychobiology. Presented ... at Columbia University Medical Center and the Sackler ...
... powerful new tool in the fight against deficiencies in ... in 40 million children annually, and increased health risks ... , This tool consists of "a new method ... enable developing countries to identify and increase cultivation of ...
Other Biology News:World-leading journal publishes special issue on UN/GA 2World-leading journal publishes special issue on UN/GA 3Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize 2New way to produce high-vitamin corn could improve nutrition in developing countries 2New way to produce high-vitamin corn could improve nutrition in developing countries 3
Request Info...
... is a preparation of deoxyribonuclease I ... to produce 3-hydroxyl oligonucleotides. This preparation ... where maintaining the integrity of RNA ... for use with the Core Footprinting ...
... the template-directed polymerization of nucleotides into duplex ... I possesses a 3?5 exonuclease activity or ... during DNA replication, and also contains a ... to replace nucleotides in the growing strand ...
RNase-Free DNase 50 l...
Biology Products: